Cargando…
Testosterone replacement therapy and the heart: friend, foe or bystander?
The role of testosterone therapy (TTh) in cardiovascular disease (CVD) outcomes is still controversial, and it seems will remain inconclusive for the moment. An extensive body of literature has investigated the association of endogenous testosterone and use of TTh with CVD events including several m...
Autores principales: | Lopez, David S., Canfield, Steven, Wang, Run |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182236/ https://www.ncbi.nlm.nih.gov/pubmed/28078222 http://dx.doi.org/10.21037/tau.2016.10.02 |
Ejemplares similares
-
Cannabinoids in rheumatology: Friend, foe or a bystander?
por: Jain, Nibha, et al.
Publicado: (2022) -
Nicotine replacement therapy: A friend or foe
por: Devi, Rajkumari E., et al.
Publicado: (2020) -
Testosterone in COVID-19: Friend or Foe?
por: Niemann, Peter J., et al.
Publicado: (2021) -
False Tendon in Cardiovascular Diseases: Friend, Foe, or Bystander?
por: Kim, Mi-Jeong
Publicado: (2021) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)